The invention relates to the field of nano
medicine and tumor treatment, in particular to a
copper-based
metal organic framework material and application thereof to preparation of drugs for treating
copper death tumors. The invention provides a pH-responsive
copper-based
metal organic framework material ZCIF (at) GSK. The structure is based on a
zeolite imidazate framework (ZIF), Zn < 2 + > / Cu < 2 + > and 2-methylimidazole are coordinated and self-assembled, and meanwhile, an LDHA inhibitor GSK is entrapped in a pore channel. The copper-based
metal organic framework material is stable under physiological conditions, and can release Cu < 2 + > and GSK at the same time under a
tumor microenvironment and a low pH condition. Wherein GSK inhibits LDHA activity, reduces
glycolysis and promotes TCA circulation, so that the copper death sensitivity is improved; cu < 2 + > is reduced into Cu < + > under the action of FDX1, DLAT oligomerization and Fe-S cluster
protein loss are triggered, and copper death is induced. The copper-based
metal organic framework material has
tumor targeting (EPR effect) and
lysosome escape ability (
proton sponge effect), and can realize combined metabolic
reprogramming and copper death treatment.